| Accession Number: | 0000899243-21-046887 |
| Date: | 2021-12-02 |
| Issuer: | VERVE THERAPEUTICS, INC. (VERV) |
| Original Submission Date: |
ADELMAN BURT A
C/O VERVE THERAPEUTICS, INC.
500 TECHNOLOGY SQUARE, SUITE 901
CAMBRIDGE, MA 02139
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2021-12-02 | P | 4,700 | a | $31.34 | 4,700 | indirect | ||
| COMMON STOCK | 2021-12-02 | 0 | $0.00 | 409,626 | indirect |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | represents the weighted average purchase price for shares purchased in multiple transactions. purchase prices ranged from $31.13 to $31.37 per share. upon request of the staff of the securities and exchange commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. |
